Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.

Malignant diseases are the second leading cause of death in women. [1] With an incidence of 24 in 100,000, endometrial cancer is the fourth most common cancer in women. [2] When diagnosed at an early ...

Tamoxifen treatment for premenopausal women with breast cancer is independently associated with an increased risk of endometrial cancer and other uterine diseases, according to findings from a large ...

Figure 3. (A) Adenomyosis with glands (Thick arrow) in the myometrium (thin arrow). (5x, H and E stain); (B) Endometrial hyperplasia with surface lining on the right (Thick arrows), the gland to ...

Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing intrauterine system Mirena® for the ...

Clinical significance of homologous recombination deficiency (HRD) score testing in endometrial cancer patients. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...

"Endometrial hyperplasia and cancer are highly affected by obesity and lifestyle factors. Focusing on these factors in diverse communities will lead to our better understanding of these disparities.

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 We conducted a case ...

Atypical polypoid adenomyoma (APA) is a rare, benign uterine lesion defined by its complex mixture of atypical endometrial glands intermingled with a prominent smooth muscle stroma. Clinically, APAs ...